Rhumbline Advisers X Biotech Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q4 2024

A detailed history of Rhumbline Advisers transactions in X Biotech Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 19,744 shares of XBIT stock, worth $65,944. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,744
Previous 21,250 7.09%
Holding current value
$65,944
Previous $164,000 53.05%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025
SELL
$3.8 - $8.25 $5,722 - $12,424
-1,506 Reduced 7.09%
19,744 $77,000
Q3 2024

Nov 12, 2024
BUY
$5.55 - $7.95 $6,415 - $9,190
1,156 Added 5.75%
21,250 $164,000
Q2 2024

Aug 01, 2024
BUY
$4.54 - $9.89 $87,808 - $191,282
19,341 Added 2568.53%
20,094 $103,000
Q2 2023

Aug 08, 2023
BUY
$3.06 - $6.38 $2,304 - $4,804
753 New
753 $4,000
Q2 2022

Aug 11, 2022
SELL
$5.13 - $9.2 $96,177 - $172,481
-18,748 Closed
0 $0
Q1 2022

May 12, 2022
SELL
$8.64 - $11.71 $16,951 - $22,975
-1,962 Reduced 9.47%
18,748 $162,000
Q4 2021

Feb 10, 2022
SELL
$10.95 - $16.07 $5,858 - $8,597
-535 Reduced 2.52%
20,710 $231,000
Q3 2021

Nov 12, 2021
BUY
$12.95 - $18.24 $11,137 - $15,686
860 Added 4.22%
21,245 $275,000
Q2 2021

Aug 05, 2021
SELL
$15.83 - $17.84 $29,190 - $32,896
-1,844 Reduced 8.3%
20,385 $338,000
Q1 2021

May 06, 2021
SELL
$15.92 - $20.3 $10,825 - $13,804
-680 Reduced 2.97%
22,229 $382,000
Q4 2020

Feb 10, 2021
BUY
$15.65 - $19.92 $49,000 - $62,369
3,131 Added 15.83%
22,909 $359,000
Q3 2020

Nov 12, 2020
SELL
$13.97 - $21.16 $46,380 - $70,251
-3,320 Reduced 14.37%
19,778 $378,000
Q2 2020

Aug 13, 2020
BUY
$10.39 - $16.07 $69,228 - $107,074
6,663 Added 40.54%
23,098 $317,000
Q1 2020

May 06, 2020
SELL
$8.89 - $24.94 $22,269 - $62,474
-2,505 Reduced 13.23%
16,435 $175,000
Q4 2019

Feb 05, 2020
BUY
$8.33 - $19.95 $43,890 - $105,116
5,269 Added 38.54%
18,940 $354,000
Q3 2019

Oct 23, 2019
BUY
$6.86 - $10.46 $3,087 - $4,707
450 Added 3.4%
13,671 $143,000
Q2 2019

Aug 14, 2019
BUY
$6.99 - $11.27 $92,414 - $149,000
13,221 New
13,221 $100,000
Q2 2018

Aug 06, 2018
SELL
$4.04 - $5.13 $70,178 - $89,113
-17,371 Closed
0 $0
Q1 2018

May 02, 2018
SELL
$3.92 - $5.35 $1,176 - $1,605
-300 Reduced 1.7%
17,371 $93,000
Q3 2017

Nov 06, 2017
BUY
$4.14 - $5.12 $73,157 - $90,475
17,671
17,671 $77,000

Others Institutions Holding XBIT

# of Institutions
52
Shares Held
4.9M
Call Options Held
0
Put Options Held
0
View Full List

About XBiotech Inc.

XBIT Quotes by TradingView
  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $102M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email